Many patients with overweight or obesity discontinue glucagon-like peptide-1 (GLP-1) receptor agonist therapy within o ...

More and more Americans are turning to GLP-1 injections to lose weight. FOX 7 Austin's Rebecca Thomas spoke to an Austin physician to discuss.

Obesity is an epidemic in the United States, but more people are shedding pounds with the help of weight loss drugs.

Telogen effluvium (a type of hair loss) may also occur after weight loss. Some of the GLP-1 agonists are used for weight loss. While doctors do not prescribe Mounjaro for weight loss, it can cause ...

GLP-1 agonist semaglutide is the active ingredient in Novo Nordisk's blockbuster weight-loss drug Wegovy, which achieved sales of around $8 billion last year. Supply constraints have meant that ...

GLP1RA mimic the GLP-1 hormone in the body that helps control insulin and blood glucose levels and promotes feelings of satiety. GLP-1 binds to GLP1R on cells in the brain and pancreas.

People who take weight-loss drugs based on GLP-1 receptor agonists seem to have reduced risk for a litany of diseases, including Alzheimer's, but an increase in some other conditions like kidney ...

Ozempic is a brand-name version of semaglutide, an injectable glucagon-like peptide-1 (GLP-1) receptor agonist medication ... prescribed off-label for weight loss via brands like Ozempic.

Independence Blue Cross began limiting coverage of GLP-1 drugs on Jan. 1 to some medical conditions, but not obesity or weight loss.

If you continue to have this issue please contact [email protected]. GLP-1 receptor agonist use before pregnancy was tied to lower risks for hypertensive disorders of pregnancy and ...